HomeCompanies › AUTL

Autolus Therapeutics

Most recent annual filing: 2026-03-27

Catalyst timeline

10 trackedQuarter catalyst calendar →
  1. CARLYSLE SLE Ph1 interimYear-end 2026CARLYSLE SLE Ph1 interim, Year-end 2026, notable
  2. ALARIC AL Ph1 interimYear-end 2026ALARIC AL Ph1 interim, Year-end 2026, notable
  3. AUTO1/22 CARPALL readoutlate 2026AUTO1/22 CARPALL readout, late 2026, notable
  4. AUTO8 readoutYE 2026AUTO8 readout, YE 2026, notable
  5. BOBCAT MS Ph1 interim1Q 2027BOBCAT MS Ph1 interim, 1Q 2027, major
  6. BOBCAT MS Ph2 readout1Q 2027BOBCAT MS Ph2 readout, 1Q 2027, material
  7. Perceptive Note Facility filingJan 30, 2027Perceptive Note Facility filing, Jan 30, 2027, routine
  8. CATULUS Pediatric r Ph2 toplineYear-end 2027CATULUS Pediatric r Ph2 topline, Year-end 2027, material
  9. Company cash runway corporate update4Q 2027Company cash runway corporate update, 4Q 2027, routine
  10. LUMINA LN Ph2 topline2028LUMINA LN Ph2 topline, 2028, major

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (12 active programs)

AUCATZYL

obecabtagene autoleucel · obe-cel · AUTO1
Cell Target: CD19

Biotech Distilled coverage (3)

Articles open on Substack. Some deep dives are subscriber-only.